Everest Medicines

BiotechnologySeries CNew York, USeverestmedicines.com

Latest round

Series C

Last raised

May 2020

Total raised

$310M

Investors

12

About Everest Medicines

Founded in 2017 and based in New York, US, Everest Medicines Ltd. operates as a biopharmaceutical company that develops drug candidates for oncology, immunology, cardio-renal disease, and infectious diseases.HK. The company's clinical and regulatory teams focus on licensing, developing, and commercializing innovative clinical-stage drug candidates, including Trodelvy, FGF401, Etrasimod, Nefecon, Xerava, VNRX-5133, and SPR206, a treatment for multi-drug resistant (MDR) Gram-negative bacterial infections. Everest Medicines Ltd. agreed with Spero Therapeutics to develop, manufacture, and commercialize SPR206, a treatment for MDR (multi-drug resistant) bacterial infections, in greater China, South Korea, and certain Southeast Asian countries.

Who invested in Everest Medicines

12 investors across 2 rounds

See all investors in Everest Medicines

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    May 29, 2020

    Amount

    $260M

    Investors

    Locked

  2. Series A

    Feb 1, 2018

    Amount

    $50M

    Investors

    Locked

Questions about Everest Medicines

Who invested in Everest Medicines?

Everest Medicines has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Everest Medicines raised?

Everest Medicines has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Everest Medicines last raise money?

Everest Medicines's most recent round on record is a Series C, in May 2020.

What does Everest Medicines do?

Founded in 2017 and based in New York, US, Everest Medicines Ltd.

Where is Everest Medicines headquartered?

Everest Medicines is headquartered in New York, US.

Which VCs invest in companies like Everest Medicines?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Everest Medicines's stage. Their profiles are linked below.

Raising like Everest Medicines? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.